The dust up between St. Jude Medical and Muddy Waters is nothing short of a cybersecurity nightmare – even for companies that have a solid security plan in place. The medtech community needs to better understand it and keep a close eye on the developments. Essentially, it represents an ethical gray area on the part of cybersecurity research firms. Although it is likely that an SEC investigation is in process, protecting medical technology companies needs to happen quickly. In this podcast, Stephanie Domas, lead medical device security engineer at Battelle, explains the dynamics at play between MedSec, the security research firm, short seller Muddy Waters, and St. Jude Medical.
